Search research articles
Contact Us
Filters
Showing results (101-110 of 329) with videos related to
Page
of 33
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 24, 2025
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial
Jessica Henry, Bruna Giribaldi, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)
|
July 21, 2010
Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic review
Berta Garcia de Miguel, David J Nutt, Sean D Hood, et al.
Drugs & Aging
|
June 16, 2024
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well-Being: Findings from T21
Michael T Lynskey, Hannah Thurgur, Alkyoni Athanasiou-Fragkouli, et al.
Journal of Affective Disorders
|
June 12, 2010
Cytokine levels in euthymic bipolar patients
Sinan Guloksuz, Esin Aktas Cetin, Turan Cetin, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
March 9, 2005
Synthesis of 2,3,5,6-tetrahydro-3H-imidazo[2,1-b] [1,3,5]benzotriazepines and their oxidative ring contraction into 1-(4,5-dihydro-1H-imidazol-2-yl)-1H-benzimidazoles
Franciszek Saczewski, Ewa Kobierska, Robin J Tyacke, et al.
Medicinal Research Reviews
|
June 16, 2011
5-HT radioligands for human brain imaging with PET and SPECT
Louise M Paterson, Birgitte R Kornum, David J Nutt, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 11, 2009
Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression
Eduard Maron, Anu Tammiste, Kristi Kallassalu, et al.
Neuropharmacology
|
September 25, 2007
Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist
David J Nutt, Marie Besson, Susan J Wilson, et al.
Molecular Psychiatry
|
September 27, 2023
Neuroimaging in psychedelic drug development: past, present, and future
Matthew B Wall, Rebecca Harding, Rayyan Zafar, et al.
Pharmacology & Therapeutics
|
May 24, 2022
Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research
Stephanie L Bourke, Anne Katrin Schlag, Saoirse Elizabeth O'Sullivan, et al.
Page
of 33
Search research articles
Search
Showing results (101-110 of 329) with videos related to
Sort By:
Page
of 33
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 24, 2025
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial
Jessica Henry, Bruna Giribaldi, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)
|
July 21, 2010
Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic review
Berta Garcia de Miguel, David J Nutt, Sean D Hood, et al.
Drugs & Aging
|
June 16, 2024
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well-Being: Findings from T21
Michael T Lynskey, Hannah Thurgur, Alkyoni Athanasiou-Fragkouli, et al.
Journal of Affective Disorders
|
June 12, 2010
Cytokine levels in euthymic bipolar patients
Sinan Guloksuz, Esin Aktas Cetin, Turan Cetin, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
March 9, 2005
Synthesis of 2,3,5,6-tetrahydro-3H-imidazo[2,1-b] [1,3,5]benzotriazepines and their oxidative ring contraction into 1-(4,5-dihydro-1H-imidazol-2-yl)-1H-benzimidazoles
Franciszek Saczewski, Ewa Kobierska, Robin J Tyacke, et al.
Medicinal Research Reviews
|
June 16, 2011
5-HT radioligands for human brain imaging with PET and SPECT
Louise M Paterson, Birgitte R Kornum, David J Nutt, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 11, 2009
Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression
Eduard Maron, Anu Tammiste, Kristi Kallassalu, et al.
Neuropharmacology
|
September 25, 2007
Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist
David J Nutt, Marie Besson, Susan J Wilson, et al.
Molecular Psychiatry
|
September 27, 2023
Neuroimaging in psychedelic drug development: past, present, and future
Matthew B Wall, Rebecca Harding, Rayyan Zafar, et al.
Pharmacology & Therapeutics
|
May 24, 2022
Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research
Stephanie L Bourke, Anne Katrin Schlag, Saoirse Elizabeth O'Sullivan, et al.
Page
of 33